Top Therapeutic Efficacy Globally

ntil now more than 1500 patients coming from over 80 countries and regions in the world have received cell based therapy of Neurorestoratology at Bejing Hongtianji Neuroscience Academy (BHNA) and lots of patients are waiting for a treatment schedule. For most of them here is the worthy place to get functional neurorestoration. Here are physicians with the most experiences of neurorestorative treatment, patients coming from the most countries in the world, the best leading cell based therapy of neurorestoratology worldwide, the top therapeutic efficacy globally.

Since 2001 Professor Hongyun Huang, the president of BHNA has been conducting olfactory ensheathing cell (OEC) transplantation of clinical study for chronic spinal cord injury. The results are quite promising and have changed the traditional concept that functional neurorestoration cannot occur with complete chronic spinal cord injuries. Under his direction the Chinese scientists of BHNA then developed OEC transplantation as a treating method for many other types of other central nervous system (CNS) diseases. Recent four years, OECs were combined with other kinds of cells (including neural stem/progenitor cell, Schwann cell, bone morrow stromal cell, umbilical cord blood cell or umbilical cord stromal cell and soon on) to treat central nervous system diseases, such as Sequel of serious traumatic brain damage, Stroke (cerebral infarction and hemorrhage), Amyotrophic lateral sclerosis (ALS) or Motor neuron disease (MND), Alzheimer's disease (AD), Parkinson's disease (PD), Myelitis, Multiple sclerosis (MS), Friedreich's ataxia, Olivopontocerebellar atrophy, Adrenoleucodystrophy (ALD), Persistent vegetative status, Front temporal dementia, Cerebral palsy, Muscular dystrophy, etc (for more information please visit ).

And patients showed better functional neurorestoration, such as easier movement, more sensation, better bowel/bladder control, muscular stronger, better balance, easier walking, etc (for patients’ medical data please visit ).

The research and achievements are deeply consistent with the principle of clinical cellular application “MMMC”, that is, multiple courses, multiple routes, multiple cells, and combined strategies such as neuromodulation or neurostimulation, bioengineering and tissue engineering, medicine and factors. This “MMMC” principle may be the reason why patients can get the best therapeutic results at BHNA.

It should highlight value any functional neurorestoration which can be gotten today because any little progress in neurorestoratology is not easily gotten; hope to get more tomorrow because many scientists and physicians are dedicating themselves to neurorestoratology.